93 related articles for article (PubMed ID: 1388327)
1. Effect of gallopamil on electrophysiologic abnormalities and ventricular arrhythmias associated with left ventricular hypertrophy in the feline heart.
Kowey PR; O'Brien R; Wu Y; Sewter J; Sokil A; Nocella J; Rials SJ
Am Heart J; 1992 Oct; 124(4):898-905. PubMed ID: 1388327
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade.
Kowey PR; Friechling TD; Sewter J; Wu Y; Sokil A; Paul J; Nocella J
Circulation; 1991 Jun; 83(6):2067-75. PubMed ID: 1645624
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects of left ventricular hypertrophy in the intact cat.
Shechter JA; O'Connor KM; Friehling TD; Mark R; Uboh C; Kowey PR
Am J Hypertens; 1989 Feb; 2(2 Pt 1):81-5. PubMed ID: 2521793
[TBL] [Abstract][Full Text] [Related]
4. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart.
Rials SJ; Wu Y; Ford N; Pauletto FJ; Abramson SV; Rubin AM; Marinchak RA; Kowey PR
Circulation; 1995 Jan; 91(2):426-30. PubMed ID: 7805247
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
6. Modulation of ventricular fibrillation in the isolated heart: the role of slow calcium channel activity under continuous perfusion.
Amitzur G; Pogatz V; Novikov I; Kaplinsky E; Eldar M
J Cardiovasc Pharmacol; 2000 Jan; 35(1):16-28. PubMed ID: 10630729
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic consequences of chronic experimentally induced left ventricular pressure overload.
Cameron JS; Myerburg RJ; Wong SS; Gaide MS; Epstein K; Alvarez TR; Gelband H; Guse PA; Bassett AL
J Am Coll Cardiol; 1983 Sep; 2(3):481-7. PubMed ID: 6192160
[TBL] [Abstract][Full Text] [Related]
8. A tale of two fibrillations.
Chen PS; Wu TJ; Ting CT; Karagueuzian HS; Garfinkel A; Lin SF; Weiss JN
Circulation; 2003 Nov; 108(19):2298-303. PubMed ID: 14609997
[No Abstract] [Full Text] [Related]
9. The effect of beta-adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models.
Luketich J; Friehling TD; O'Connor KM; Kowey PR
Am Heart J; 1989 Aug; 118(2):265-71. PubMed ID: 2750648
[TBL] [Abstract][Full Text] [Related]
10. Small-Conductance Calcium-Activated Potassium Current Is Activated During Hypokalemia and Masks Short-Term Cardiac Memory Induced by Ventricular Pacing.
Chan YH; Tsai WC; Ko JS; Yin D; Chang PC; Rubart M; Weiss JN; Everett TH; Lin SF; Chen PS
Circulation; 2015 Oct; 132(15):1377-86. PubMed ID: 26362634
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmia inducibility and ventricular vulnerability in a chronic feline infarction model.
Wetstein L; Mark R; Kelliher GJ; Friehling T; O'Connor KM; Kowey PR
Am Heart J; 1985 Nov; 110(5):955-60. PubMed ID: 4061270
[TBL] [Abstract][Full Text] [Related]
12. Two types of ventricular fibrillation in isolated rabbit hearts: importance of excitability and action potential duration restitution.
Wu TJ; Lin SF; Weiss JN; Ting CT; Chen PS
Circulation; 2002 Oct; 106(14):1859-66. PubMed ID: 12356642
[TBL] [Abstract][Full Text] [Related]
13. Frequency-dependent electrophysiologic effects of amiodarone in humans.
Sager PT; Uppal P; Follmer C; Antimisiaris M; Pruitt C; Singh BN
Circulation; 1993 Sep; 88(3):1063-71. PubMed ID: 8353868
[TBL] [Abstract][Full Text] [Related]
14. Renal denervation decreases susceptibility of the heart to ventricular fibrillation in a canine model of chronic kidney disease.
Tang X; Shi L; Cui X; Yu Y; Qi T; Chen C; Tang X
Exp Physiol; 2017 Nov; 102(11):1414-1423. PubMed ID: 28833735
[TBL] [Abstract][Full Text] [Related]
15. Use of calcium antagonists for cardiac arrhythmias.
Singh BN; Nademanee K
Am J Cardiol; 1987 Jan; 59(3):153B-162B. PubMed ID: 2433930
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
Roden DM; Lee JT; Woosley RL; Echt DS
Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
[TBL] [Abstract][Full Text] [Related]
17. [Regularization of ventricular intervals in atrial fibrillation--electrophysiologic findings on the underlying mechanism].
Neuss H; Golling FR; Schlepper M; Thormann J; Weissmüller P; Kindler M
Z Kardiol; 1984 Feb; 73(2):106-12. PubMed ID: 6719983
[TBL] [Abstract][Full Text] [Related]
18. Role of extrastimulus prematurity and intraventricular conduction time in inducing ventricular tachycardia or ventricular fibrillation secondary to coronary artery disease.
Gillis AM; Winkle RA; Echt DS
Am J Cardiol; 1987 Sep; 60(7):590-5. PubMed ID: 3630942
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
Bargheer K; Bode F; Klein HU; Trappe HJ; Franz MR; Lichtlen PR
Eur Heart J; 1994 Oct; 15(10):1409-14. PubMed ID: 7821321
[TBL] [Abstract][Full Text] [Related]
20. Comparative investigations on the antiarrhythmic and electrophysiological effects of various calcium antagonists (diltiazem, verapamil, gallopamil, nifedipine) following acute transient coronary artery occlusion and reperfusion.
Haverkamp W; Thale J; Gülker H; Hindricks G; Bender F
Eur Heart J; 1987 Aug; 8 Suppl D():117-28. PubMed ID: 3678252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
